HOME › Press Releases › Cell Isolation/Cell Separation Market worth 7.89 Billion USD by 2021
Cell Isolation/Cell Separation Market worth 7.89 Billion USD by 2021
The report "Cell Isolation/Cell Separation Market by Product (Reagents, Media, Serum, Beads, Centrifuge), Cell Type (Human, Stem, Animal), Technique (Surface marker, Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) - Global Forecast to 2021", The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell isolation market along with the estimates and forecasts of the revenue and market shareanalysis.
Browse 124 market data tables and 46 figures spread through 172 pages and in-depth TOC on “Cell Isolation/Cell Separation Market by Product (Reagents, Media, Serum, Beads, Centrifuge), Cell Type (Human, Stem, Animal), Technique (Surface marker, Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) - Global Forecast to 2021”
Early buyers will receive 10% customization on reports.
The global cell isolation market is expected to reach USD 7.89 Billion by 2021 from USD 3.57 Billion in 2016 at a CAGR of 17.2% from 2016 to 2021. The major factors driving the growth of this market are the increasing government funding for cell based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, growing focus on personalized medicine, and expanding biotechnology and biopharmaceutical industries.
The report segments this market on the basis of product, cell type, technique, application, and end user. On the basis of product, the cell isolation market is segmented into consumables and instruments. The consumables segment is expected to account for the largest share of the market during the forecast period. The large share of this segment is attributed to increasing investments by companies to develop advanced products, increasing number of regulatory approvals, and rising government initiatives for enhancing cell-based research.
Based on cell type, the cell isolation market is segmented into human cells and animal cells. The human cells segment is projected to witness the largest growth in this market due to technological advancements; increasing focus on human stem cell isolation; and wide usage of isolated differentiated human cells in research, academics, therapeutics, and biopharmaceutical & biotechnology industries.
Based on technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment is projected to witness the largest growth during the forecast period primarily due to the wide usage of this technique among end users. This system is used on a large scale by biotechnology and biopharmaceutical companies as well as on a small scale by clinical research organizations and academia for manufacturing vaccines, enzymes, and antibodies.
Based on application, the cell isolation market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics. The biomolecule isolation segment is projected to witness the highest growth rate in this market primarily due to increasing company investments to develop new biopharmaceutical products.
Based on region, the global cell isolation market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The Asian market is expected to grow at the highest CAGR during the forecast period. Factors such as increasing interest in emerging markets, government support, and high prevalence of diseases are driving the growth of this market.
The key players in the cell isolation market include by Beckman Coulter, Inc. (U.S.), BD Biosciences (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Bio-Rad Laboratories Inc. (U.S.).
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India